Skip to main content
. 2022 May 10;22:164. doi: 10.1186/s12893-022-01614-y

Table 1.

Patients’ clinical characteristics before and after PSM

Parameter Before PSM After PSM
LCA preservation (n = 61) LCA nonpreservation (n = 155) P value LCA preservation (n = 60) LCA nonpreservation (n = 60) P value
Age 59.5 ± 11.3 59.0 ± 11.0 0.784 59.5 ± 11.4 60.3 ± 10.5 0.696
Sex 0.334 0.855
 Male 31 (50.8) 90 (58.1) 31 (51.7) 30 (50.0)
 Female 30 (49.2) 65 (41.9) 29 (48.3) 30 (50.0)
BMI (kg/m2) 23.1 ± 3.3 23.1 ± 2.8 0.841 23.1 ± 3.3 23.2 ± 2.8 0.846
ASA classification 0.190
 I 26 (42.6) 81 (52.2) 26 (43.3) 26 (43.3) 0.843
 II 28 (45.9) 61 (39.4) 27 (45.0) 29 (48.3)
 III 7 (11.5) 13 (8.4) 7 (11.7) 5 (8.4)
Tumor location 0.719 0.752
 Lower (≤ 5 cm) 16 (26.2) 54 (34.8) 16 (26.7) 14 (23.3)
 Middle (5.1–10 cm) 37 (60.7) 71 (45.8) 36 (60.0) 38 (63.4)
 Upper (10.1–15 cm) 8 (13.1) 30 (19.4) 8 (13.3) 8 (13.3)
Pathological stage 0.643 0.866
 Stage 0 4 (6.5) 9 (5.8) 4 (6.7) 5 (8.3)
 Stage 1 18 (29.5) 39 (25.2) 18 (30.0) 14 (23.3)
 Stage 2 17 (27.9) 45 (29.0) 17 (28.3) 20 (33.3)
 Stage 3 15 (24.6) 50 (32.3) 15 (25.0) 16 (26.7)
 Stage 4 7 (11.5) 12 (7.7) 6 (10.0) 5 (8.4)
Neoadjuvant therapy 12 (19.7) 34 (21.9) 0.715 12 (20.0) 15 (25.0) 0.512
TaTME 0.019a 0.817
 Yes 11 (18.0) 53 (34.2) 11 (18.3) 12 (20.0)
 No 50 (82.0) 102 (65.8) 49 (81.7) 48 (80.0)
Ileostomy 0.252 1.000
 Yes 33 (54.1) 97 (62.6) 33 (55.0) 33 (55.0)
 No 28 (45.9) 58 (37.4) 27 (45.0) 27 (45.0)
Surgical approach 0.058 0.702
 Laparoscope 40 (65.6) 121 (78.1) 40 (66.7) 38 (63.3)
 Robotic 21 (34.4) 34 (21.9) 20 (33.3) 22 (36.7)

PSM propensity score matching; LCA left colic artery; BMI body mass index (kg/m2); ASA American Society of Anesthesiologists; TaTME transanal total mesorectal excision